Clovis | 3 buy scenarios | One trial at a timeGreat run Clovis had the last days. However i prefer not to buy into runs and wait till my requirements are met.
I marked 3 possible places where i would buy if the following would happen:
- Price gets above the level
- Open and close of a monthly candle above the level, then buy
- Targets are based on the next resistance level
- Stop- Loss: None
Good luck
Disclaimer:
- This information does not constitute as financial advice and is only for educational purposes. I am not your financial advisor.
- You trade entirely at your own risk
- Make your own research
- Finance and trading is evil, capitalism is bad, duh ;)
Clovisoncology
Clovis Oncology CLVS Option CallsBased on my research, I think that the $3 strike price expiring July 15, with the price of $0.21 or lower is what I would pick right now.
As you know, the OTM options can be profitable even if they don`t reach the strike price.
If the stock moves closer to the strike price after you enter the trade, or if there is a rapid increase in Implied Volatility, you can sell the option for a profit.
My personal goal is to transform $10k into $1Million from options trading.
Thank you for viewing my out of the money option calls and puts ideas!
CLVS back on the low lowCLVS is now back at its November 2020 low. The interesting part of this trend is that it also managed to test, hold, and bounce off of an almost identical level (strong support?). As of Friday afternoon shares retested an interim area of higher traffic that was support earlier in August and late July but now appears to have become a resistance level over the last 3 sessions at least. With the "short squeeze stocks" conversation building steam, it could be interesting for CLVS. Finviz shows the short float percentage at 27% right now.
" The biotech sector may also host some of the other heavily shorted stocks. Phase trial data, scientific reports, and the like all play a role in directional momentum. In this case, Clovis has felt some pressure over the last few quarters. Clinical data on its FAP-2286 platform, along with missed earings, haven’t helped the cause. Then you’ve got news of large, multi-million dollar fundraising initiatives adding more pressure as well. Needless to say, it has happened to hopefully advance the company’s pipeline...Clovis specializes in developing cancer treatments. Its lead candidate Rubraca is an oral treatment being developed in multiple types of tumors. These include ovarian and prostate cancers. It’s approved in the US for maintenance treatment in adults with recurrent epithelial, ovarian, fallopian tube, or primary peritoneal cancers...As far as CLVS being considered one of the “short squeeze stocks,” outlets show that the penny stock’s short-interest sits around 27%. Of course, it isn’t as high as some of the others on this list. However, anything over 20%, by most accounts, can be considered high. "
Quote Source & Read More: 4 Short Squeeze Penny Stocks To Watch After SPRT Stock’s 1,309% Run
CLVS Clovis Oncology Price TargetCLVS Clovis Oncology is sitting at a strong support area ready for a bounce.
My Price target is the 10usd resistance level
On 5/5/2021 HC Wainwright brokerage Lowered the Price Target for CLVS Clovis Oncology to Buy Rating from $13.00 to$12.00
